Olanzapine vs haloperidol: treating delirium in a critical care setting

[1]  Y. Skrobik.  Haloperidol should be used sparingly. , 2002, Critical care medicine.

[2]  S. Caroff,et al.  Neuroleptic malignant syndrome in the critical care unit. , 2002, Critical care medicine.

[3]  S. Dial,et al.  Managing Acute Delirium in the Intensive Care Unit , 2002 .

[4]  William Breitbart,et al.  An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. , 2002, Psychosomatics.

[5]  W. Breitbart,et al.  The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. , 2002, Psychosomatics.

[6]  Michal Abrahamowicz,et al.  Delirium predicts 12-month mortality. , 2002, Archives of internal medicine.

[7]  Philip D Lumb,et al.  Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. , 2002, Critical care medicine.

[8]  G. Bernard,et al.  Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). , 2001, JAMA.

[9]  G. Bernard,et al.  The impact of delirium in the intensive care unit on hospital length of stay , 2001, Intensive Care Medicine.

[10]  J. Chae,et al.  An open pilot trial of olanzapine for delirium in the Korean population , 2001, Psychiatry and clinical neurosciences.

[11]  M. Aldemir,et al.  Predisposing factors for delirium in the surgical intensive care unit , 2001, Critical care.

[12]  Y. Skrobik,et al.  Delirium in an intensive care unit: a study of risk factors , 2001, Intensive Care Medicine.

[13]  Y. Skrobik,et al.  Intensive Care Delirium Screening Checklist: evaluation of a new screening tool , 2001, Intensive Care Medicine.

[14]  J. Kwentus.  Practice Guidelines for the Treatment of Patients With Delirium , 2001 .

[15]  C. Ryan,et al.  Intensive care unit syndrome: a dangerous misnomer. , 2000, Archives of internal medicine.

[16]  Trzepacz Pt.  Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. , 2000 .

[17]  A. Denault,et al.  Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[18]  Candace S. Brown,et al.  Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy , 1999, The Annals of pharmacotherapy.

[19]  F. Bellavance,et al.  Reliability and Validity of a New Measure of Severity of Delirium , 1998, International Psychogeriatrics.

[20]  P. Masand,et al.  Olanzapine in the treatment of delirium. , 1998, Psychosomatics.

[21]  R. Ilchef,et al.  Neuroleptic-Induced Laryngeal Dystonia Can Mimic Anaphylaxis , 1997, The Australian and New Zealand journal of psychiatry.

[22]  S. C. Armstrong,et al.  The misdiagnosis of delirium. , 1997, Psychosomatics.

[23]  P. Masand,et al.  Use of Risperidone in Delirium: Case Reports , 1997, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[24]  G. Bashford,et al.  Drug-Induced Parkinsonism Associated with Dysphagia and Aspiration: A Brief Report , 1996, Journal of geriatric psychiatry and neurology.

[25]  S. Kapur,et al.  High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. , 1996, The American journal of psychiatry.

[26]  L. E. Hollistar,et al.  Antipsychotic drug-induced dysphoria. , 1996, The British journal of psychiatry : the journal of mental science.

[27]  S. Endo,et al.  Delirium in critical care unit patients admitted through an emergency room. , 1995, General hospital psychiatry.

[28]  S. Levkoff,et al.  An Empirical Study of Delirium Subtypes , 1992, British Journal of Psychiatry.

[29]  M. Folstein,et al.  Delirium: Phenomenologic and Etiologic Subtypes , 1991, International Psychogeriatrics.

[30]  S. Caroff,et al.  Neuroleptic malignant syndrome , 1980, Psychopharmacology bulletin.

[31]  M. Ramsay,et al.  Controlled Sedation with Alphaxalone-Alphadolone , 1974, British medical journal.

[32]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[33]  A. Leshner.  Science is revolutionizing our view of addiction--and what to do about it. , 1999, The American journal of psychiatry.

[34]  G. Murray,et al.  Decreased extrapyramidal symptoms with intravenous haloperidol. , 1987, The Journal of clinical psychiatry.